Selank and Semax: Nootropic Peptides Compared

Russian Nootropic Peptides: An Introduction

Selank and Semax are two synthetic peptides developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. Both are approved medications in Russia and several other CIS countries, with decades of clinical use and research. They represent a uniquely Russian approach to cognitive enhancement through peptide-based neuromodulation.

Semax: The Focus Peptide

What It Is

Semax is a synthetic heptapeptide analog of ACTH(4-10), the fragment of adrenocorticotropic hormone responsible for its neurotrophic effects. The sequence is Met-Glu-His-Phe-Pro-Gly-Pro, with the C-terminal Pro-Gly-Pro extension providing resistance to enzymatic degradation and extending the half-life from minutes to several hours.

Mechanism of Action

• BDNF upregulation -- Semax significantly increases brain-derived neurotrophic factor (BDNF), a key protein for neuronal survival, growth, and synaptic plasticity. BDNF is central to learning and memory formation.
• Dopamine and serotonin modulation -- Research shows Semax influences dopaminergic and serotonergic neurotransmission, contributing to improved motivation, focus, and mood.
• Neuroprotection -- Semax has demonstrated protective effects against ischemic brain injury, oxidative stress, and glutamate excitotoxicity in animal models.
• NGF enhancement -- The peptide also increases nerve growth factor (NGF), supporting peripheral and central nervous system health.

Clinical Evidence

In Russia, Semax is approved for the treatment of cognitive disorders, stroke recovery, peptic ulcers (due to anti-stress effects), and optic nerve disease. Clinical studies have shown improved memory and attention in elderly patients with cognitive decline, accelerated recovery of neurological function after ischemic stroke, and enhanced cognitive performance under stress conditions.

Selank: The Calming Cognitive Enhancer

What It Is

Selank is a synthetic analog of tuftsin (Thr-Lys-Pro-Arg), an immunomodulatory peptide naturally produced during immunoglobulin G (IgG) proteolysis. The Selank sequence adds Gly-Pro to the C-terminus for enzymatic stability, giving it the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro.

Mechanism of Action

• GABAergic modulation -- Selank enhances GABA neurotransmission, producing anxiolytic (anti-anxiety) effects comparable to benzodiazepines but without sedation, dependence, or withdrawal.
• Serotonin metabolism -- Research shows Selank influences serotonin metabolism, particularly the balance between serotonin and its metabolite 5-HIAA, contributing to mood stabilization.
• Immune modulation -- As a tuftsin analog, Selank modulates immune function, including NK cell activity and cytokine balance. This dual cognitive-immune effect is unique among nootropics.
• Enkephalin stabilization -- Selank inhibits enkephalin-degrading enzymes, extending the activity of endogenous opioid peptides that contribute to stress resilience and emotional regulation.

Head-to-Head Comparison

Dosing Protocols

Semax

• Nasal: 200-600 mcg per nostril, 2-3 times daily
• Subcutaneous: 100-500 mcg, 1-2 times daily
• Cycle: 10-20 days on, 10-20 days off

Selank

• Nasal: 250-500 mcg per nostril, 2-3 times daily
• Subcutaneous: 250-750 mcg, 1-2 times daily
• Cycle: 14-21 days on, 14-21 days off (though some protocols allow continuous use)

Stacking Selank + Semax

Many users combine both peptides for balanced cognitive enhancement: Semax provides the drive, focus, and neurotrophic support, while Selank provides calm, reduces anxiety, and stabilizes mood. This combination is especially popular among individuals who find stimulating nootropics to increase anxiety, as Selank counterbalances the activating effects of Semax.

Safety and Side Effects

Both peptides have extensive safety data from decades of clinical use in Russia. Neither shows addictive potential, tolerance development, or withdrawal effects. The most common side effects are mild nasal irritation (with nasal use), occasional headache, and rare dizziness. Semax may cause mild insomnia if taken too late in the day, while Selank may cause mild drowsiness in sensitive individuals.